FDA nominee to recuse himself from decisions on more than 20 health-care companies

President Trump's nominee to lead the Food and Drug Administration plans to recuse himself for a year from agency decisions involving more than 20 companies that he has worked for, invested in or had some other kind of financial relationship with, according to federal ethics filings. Scott Gottlieb, a physician who served as deputy FDA […]

Related:
Senator to investigate opioid makers’ role in drug crisis
More than two-thirds of cancer mutations are due to random DNA copying errors, study says
What the top U.S. health official should be saying on vaccines

Share Share Tweet Share Share Share

Home

Thanks For You Reading The Post We are very happy for you to come to our site. Our Website Domain name https://leomedtrends.blogspot.com/.